Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether zanamivir aqueous solution given by
intravenous injection is safe in treating hospitalized patients with confirmed influenza
infection. A single arm open-label design has been selected to achieve the primary objective
of providing regulatory authorities with safety data on IV zanamivir.